Talis Biomedical Corp

NASDAQ:TLISUnited States

Talis Biomedical Corporation. (Talis) Is engaged in developing molecular diagnostic tests for infectious diseases at the point of care. The Company is focused on developing and commercializing products that are designed to enable molecular testing for infectious diseases and other conditions. Talis is developing the Talis One platform, a cloud-enabled molecular diagnostic platform. The Talis One platform comprises a compact instrument, single-use test cartridges and software, including a central cloud database, which work together and are designed to provide central laboratory levels of accuracy. The platform is designed for use in non-laboratory settings, such as physicians’ offices, hospital emergency departments, urgent care clinics, ambulatory surgery centers, assisted living facilities, and cancer treatment and dialysis centers. The Company is also developing Talis One tests for respiratory infections, infections related to women’s health and sexually transmitted infections.

Contact Information

Headquarters

230 Constitution DriveMENLO PARK, CA, United States 94025

Phone

650-433-3000

Fax

302-636-5454

Executives

Chief Executive Officer, Director

Robert Kelley

Co-Founder, Director

Rustem Ismagilov

Chief Financial Officer

J. Roger Moody

Independent Director

Felix Baker

Independent Director

Raymond Cheong